norgestrel has been researched along with Experimental Mammary Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casey, HW; Geil, RG; Giles, RC; Kwapien, RP | 2 |
| Berliner, VR | 1 |
| Guggiari, M; Rudali, G | 1 |
4 other study(ies) available for norgestrel and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Malignant mammary tumors in beagle dogs dosed with investigational oral contraceptive steroids.
Topics: Adenocarcinoma; Animals; Carcinogens; Carcinoma, Squamous Cell; Contraceptives, Oral; Contraceptives, Oral, Combined; Dogs; Female; Fibrosarcoma; Lung Neoplasms; Mammary Neoplasms, Experimental; Mestranol; Norgestrel; Norpregnadienes; Pregnenes | 1980 |
Mammary nodules in beagle dogs administered investigational oral contraceptive steroids.
Topics: Adenoma; Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Dogs; Dose-Response Relationship, Drug; Female; Mammary Neoplasms, Experimental; Mestranol; Neoplasm Regression, Spontaneous; Norgestrel; Norpregnadienes; Pregnenes; Progesterone Congeners; Steroids, Chlorinated; Time Factors | 1978 |
U.S. Food and Drug Administration requirements for toxicity testing of contraceptive products.
Topics: Animals; Contraceptives, Oral; Dogs; Drug Evaluation; Drug Evaluation, Preclinical; Estrogens; Female; Haplorhini; Humans; Legislation, Drug; Mammary Neoplasms, Experimental; Mestranol; Methods; Norgestrel; Progestins; Prostaglandins; Rats; Time Factors; United States; United States Food and Drug Administration | 1974 |
[Carcinogenic effect of two norgestrels on mouse mammary gland].
Topics: Animals; Castration; Female; Male; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mestranol; Mice; Mice, Inbred C3H; Norgestrel; Stereoisomerism | 1974 |